V
Vera Therapeutics, Inc.
VERA · NASDAQ · Healthcare · 2.3B
Price · close
$32.27
+3.25% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.4×
Enterprise value / EBITDAEV/EBITDA
-6.2×
Free cash flow yieldFCF yield
-11.7%
Return on equityROE
-49.6%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
1.0×
Interest coverage
-41.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.